Trial · NCT01519544
Comparison of Temazepam and Acetazolamide to Treat Difficulty Sleeping at High Altitude
NCT01519544, Not applicable, Completed, Massachusetts General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Temazepam and Acetazolamide to Treat Difficulty Sleeping at High Altitude. Trials, record NCT01519544. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01519544
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Temazepam and Acetazolamide to Treat Difficulty Sleeping at High Altitude
- NCT number
- NCT01519544
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 34 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- High-altitude Sleep Disturbance
- Interventions
- Temazepam, Acetazolamide
- First posted
- 2012-01-27
- Last updated
- 2015-04-23
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Global assessment of sleep quality using a 100mm visual analog scale | 1 day | The morning after taking the study medication, subjects will be asked: How would you rate last night's sleep quality? They will mark their answer on a 100mm visual analog scale with 0mm representing 'worst night of sleep ever' and 100mm representing 'best night of sleep ever'. |
| Primary | The Groningen Sleep Quality Questionnaire survey | 1 day | The Groningen Sleep Quality Questionnaire survey includes fifteen questions that describe sleep onset, sleep quality, awakenings, sleep duration, and wake up quality. Survey is completed by the subject. |
| Secondary | Sleep Onset Latency | 1 day | The amount of time it takes the subject to fall asleep. Reported by the subject. |
| Secondary | Total Sleep Duration | 1 day | The total amount of time that the subject slept. Recorded by the subject. |
| Secondary | Time in Bed | 1 day | The amount of time the subject spent in bed. Recorded by the subject. |
| Secondary | Number of Awakenings | 1 day | The number of times the subject woke up from sleep. Recorded by the subject. |
| Secondary | Number of Awakenings to Urinate | 1 day | Number of time the subject woke up from sleep to use the restroom. Recorded by the subject. |
| Secondary | Wake Time After Sleep Onset | 1 day | Amount of time the subject spent awake after falling asleep. Recorded by the subject. |
| Secondary | Terminal Wakefulness | 1 day | The amount of time the subject spends in bed after waking up for the last time. Reported by the subject. |
| Secondary | Global assessment of sleep depth | 1 day | Subjects will be asked to rate the depth of sleep on a 100mm visual analog scales. |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers38
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01519544
GET https://conductscience.org/api/trials/v1/NCT01519544/papers?page=2